LUTONIX 035AV DRUG COATED BALLOON PTA CATHETER 9010 LX3575660V

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2018-06-05 for LUTONIX 035AV DRUG COATED BALLOON PTA CATHETER 9010 LX3575660V manufactured by C.r. Bard, Inc. (gfo).

Event Text Entries

[110141786] Analysis: the sample was not returned from the user facility; therefore, a device evaluation is unable to be performed. A lot history review revealed this is the only complaint associated with this lot. A review of the device history record (dhr) indicates the lot was manufactured to specification. Conclusion: the actual sample was not received for evaluation. The dhr found nothing to indicate a manufacturing related cause for this event. In the opinion of the physician, he is unsure if the occurrence of hypotension and bradycardia is related to the treatment of the lutonix dcb. The patient was previously treated, approximately two years ago, with a lutonix dcb in the same location, and the patient did not have any issues at that time. Furthermore, the patient's predilatation involved atherectomy, which may have contributed to the distal embolization. Reportedly, a clot was noted below the placed filter, which was removed through aspiration. Based on the instructions for use (ifu), the occurrence of hypotension and arrhythmias are inherent risks of any pta procedure. If additional information becomes known to the manufacturer, a supplemental report will be provided with all relevant information. The information provided by bard represents all of the known information at this time. Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
Patient Sequence No: 1, Text Type: N, H10


[110141787] It was reported that, allegedly, the patient experienced hypotension and bradycardia while the target lesion was being treated with a lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter. The health care professional (hcp) used a contralateral approach with a 6 french introducer sheath to access the patient's target lesion located in the superficial femoral artery (sfa). The hcp placed a filter, of unknown type, below the treatment location and proceeded to use a medtronic silver hawk or hawk one device to debulk the sfa. After the atherectomy, a standard cook balloon was used to pre-dilate the target lesion. Reportedly, the lutonix dcb was inflated and held at nominal pressure for two minutes. Allegedly, during the two minute inflation period, the patient? S blood pressure reportedly dropped by approximately 30 millimeter of mercury. Allegedly, the patient went into bradycardia, of which the rate is unknown. The patient's heart rate and blood pressure were reportedly normal prior to the lutonix dcb inflation. The episode of bradycardia was reportedly "brief, approximately five minutes". The hcp deflated the lutonix dcb, which resulted in the patient's heart rate returning to normal sinus rhythm. It was reported that no dissection or extravasation was found after the treatment with the lutonix dcb. Allegedly, there was some distal embolization below the filter that was removed with a pronto aspiration device. Also, there was a reported clot removed from the distal arteries after the lutonix dcb treatment. The lutonix dcb was removed without complications. The lutonix dcb was requested to be returned for evaluation. No further adverse patient outcomes were reported. In the opinion of the physician, he is unsure if the occurrence of hypotension and bradycardia is related to the treatment of the lutonix dcb. The patient was previously treated approximately two years ago with a lutonix dcb in the same location and the patient did not have any issues at that time. No further adverse patient outcomes were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3006513822-2018-00139
MDR Report Key7571332
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2018-06-05
Date of Report2018-09-28
Date of Event2018-05-10
Date Mfgr Received2018-09-28
Device Manufacturer Date2018-02-13
Date Added to Maude2018-06-05
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJOHN RISSE
Manufacturer Street9409 SCIENCE CENTER DR
Manufacturer CityNEW HOPE MN 55428
Manufacturer CountryUS
Manufacturer Postal55428
Manufacturer Phone7634632917
Manufacturer G1C.R. BARD, INC. (GFO)
Manufacturer Street289 BAY ROAD
Manufacturer CityQUEENSBURY NY 12804
Manufacturer CountryUS
Manufacturer Postal Code12804
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLUTONIX 035AV DRUG COATED BALLOON PTA CATHETER
Generic NameDRUG COATED BALLOON PTA CATHETER
Product CodePRC
Date Received2018-06-05
Model Number9010
Catalog NumberLX3575660V
Lot NumberGFCN0501
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerC.R. BARD, INC. (GFO)
Manufacturer Address289 BAY ROAD QUEENSBURY NY 12804 US 12804


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2018-06-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.